Oruka Therapeutics, Inc.
ORKA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$83,724 | – | -$9,926 | -$19,322 |
| Dep. & Amort. | $27 | – | $114 | $91 |
| Deferred Tax | $0 | – | $0 | $0 |
| Stock-Based Comp. | $0 | – | $0 | $0 |
| Change in WC | $11,591 | – | -$1,661 | -$28 |
| Other Non-Cash | $14,269 | – | $561 | $497 |
| Operating Cash Flow | -$57,837 | – | -$10,912 | -$18,762 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$189 | – | -$2 | -$43 |
| Net Acquisitions | $0 | – | $0 | $0 |
| Inv. Purchases | -$329,938 | – | $0 | $0 |
| Inv. Sales/Matur. | $0 | – | $0 | $0 |
| Other Inv. Act. | $0 | – | $0 | $0 |
| Investing Cash Flow | -$330,127 | – | -$2 | -$43 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | – | $0 | $0 |
| Stock Issued | $449,539 | – | $0 | $23,093 |
| Stock Repurch. | $0 | – | $0 | $0 |
| Dividends Paid | $0 | – | $0 | $0 |
| Other Fin. Act. | $0 | – | $0 | $0 |
| Financing Cash Flow | $449,539 | – | $0 | $23,093 |
| Forex Effect | -$37,431 | – | $0 | $0 |
| Net Chg. in Cash | $24,144 | – | -$10,914 | $4,288 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $37,431 | – | $53,359 | $49,071 |
| End Cash | $61,575 | – | $42,445 | $53,359 |
| Free Cash Flow | -$58,026 | – | -$10,914 | -$18,805 |